Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine

Journal of the American College of Cardiology

Volumn 57, Issue 3, 2011, Pages 366-375

  Morita, Norishige ^a   Lee, Jong Hwan ^a,b   Xie, Yuanfang ^a   Sovari, Ali ^a   Qu, Zhilin ^a   Weiss, James N ^a   Karagueuzian, Hrayr S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

early afterdepolarization; focal activity; optical mapping; oxidative stress; ranolazine; re entry; triggered activity; ventricular fibrillation

Indexed keywords

HYDROGEN PEROXIDE; RANOLAZINE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; HEART MUSCLE POTENTIAL; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; OXIDATIVE STRESS; PERFUSION; PRIORITY JOURNAL; RAT; SODIUM CURRENT;

ACETANILIDES; ACTION POTENTIALS; ANIMALS; MALE; PIPERAZINES; RATS; RATS, INBRED F344; SODIUM CHANNEL BLOCKERS; VENTRICULAR FIBRILLATION;

EID: 78651326450     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.07.045     Document Type: Article

References (42)

1. G.K. Moe, W.L. Rheinboldt, and J.A. Abildskov A computer model of atrial fibrillation Am Heart J 64 1964 200 220
2. F.H. Samie, O. Berenfeld, and J. Anumonwo Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation Circ Res 89 2001 1216 1223
3. T.J. Wu, S.F. Lin, J.N. Weiss, C.T. Ting, and P.S. Chen Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution Circulation 106 2002 1859 1866
4. D. Scherf Studies on auricular tachycardia caused by aconitine administration Proc Exp Biol Med 64 1947 233 239
5. M. Swissa, Z. Qu, and T. Ohara Action potential duration restitution and ventricular fibrillation due to rapid focal excitation Am J Physiol Heart Circ Physiol 282 2002 H1915 H1923
6. N. Morita, A.A. Sovari, and Y. Xie Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress Am J Physiol Heart Circ Physiol 297 2009 H1594 H1605
7. D. Sato, L.H. Xie, and A.A. Sovari Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias Proc Natl Acad Sci U S A 106 2009 2983 2988
8. Y. Song, J.C. Shryock, S. Wagner, L.S. Maier, and L. Belardinelli Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction J Pharmacol Exp Ther 318 2006 214 222
9. S. Fredj, K.J. Sampson, H. Liu, and R.S. Kass Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action Br J Pharmacol 148 2006 16 24
10. C. Antzelevitch, L. Belardinelli, and A.C. Zygmunt Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties Circulation 110 2004 904 910 (Pubitemid 39136212)
11. C. Antzelevitch, L. Belardinelli, and L. Wu Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent J Cardiovasc Pharmacol Ther 9 Suppl 1 2004 S65 S83
12. S. Sicouri, K.W. Timothy, and A.C. Zygmunt Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine Heart Rhythm 4 2007 638 647
13. L. Wu, S. Rajamani, H. Li, C.T. January, J.C. Shryock, and L. Belardinelli Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart Am J Physiol Heart Circ Physiol 297 2009 H1048 H1057
14. K. Kumar, B.D. Nearing, C.R. Bartoli, K.F. Kwaku, L. Belardinelli, and R.L. Verrier Effect of ranolazine on ventricular vulnerability and defibrillation threshold in the intact porcine heart J Cardiovasc Electrophysiol 19 2008 1073 1079
15. L.H. Xie, F. Chen, H.S. Karagueuzian, and J.N. Weiss Oxidative stress-induced afterdepolarizations and calmodulin kinase II signaling Circ Res 104 2009 79 86
16. L.S. Maier, and D.M. Bers Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond J Mol Cell Cardiol 34 2002 919 939
17. M.E. Anderson, A.P. Braun, and Y. Wu KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart J Pharmacol Exp Ther 287 1998 996 1006
18. J.R. Erickson, M.L. Joiner, and X. Guan A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation Cell 133 2008 462 474
19. C.A. Ward, and W.R. Giles Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes J Physiol 500 Pt 3 1997 631 642
20. N. Ono, H. Hayashi, and A. Kawase Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition Am J Physiol Heart Circ Physiol 292 2007 639 648
21. A. Mahajan, D. Sato, and Y. Shiferaw Modifying L-type calcium current kinetics: consequences for cardiac excitation and arrhythmia dynamics Biophys J 94 2008 411 423
22. Y.H. Kim, A. Garfinkel, and T. Ikeda Spatiotemporal complexity of ventricular fibrillation revealed by tissue mass reduction in isolated swine right ventricle Further evidence for the quasiperiodic route to chaos hypothesis J Clin Invest 100 1997 2486 2500
23. A. Garfinkel, P.S. Chen, and D.O. Walter Quasiperiodicity and chaos in cardiac fibrillation J Clin Invest 99 1997 305 314
24. M.P. Nash, A. Mourad, and R.H. Clayton Evidence for multiple mechanisms in human ventricular fibrillation Circulation 114 2006 536 542 (Pubitemid 44199642)
25. S. Rajamani, N. El-Bizri, J.C. Shryock, J.C. Makielski, and L. Belardinelli Use-dependent block of cardiac late Na(+) current by ranolazine Heart Rhythm 6 2009 1625 1631
26. J.A. Wasserstrom, R. Sharma, and M.J. O'Toole Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart J Pharmacol Exp Ther 331 2009 382 391
27. S.L. Hale, J.C. Shryock, L. Belardinelli, M. Sweeney, and R.A. Kloner Late sodium current inhibition as a new cardioprotective approach J Mol Cell Cardiol 44 2008 954 967
28. G. Antoons, A. Oros, and J.D. Beekman Late Na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model J Am Coll Cardiol 55 2010 801 809
29. J.N. Weiss, P.S. Chen, Z. Qu, H.S. Karagueuzian, and A. Garfinkel Ventricular fibrillation: how do we stop the waves from breaking? Circ Res 87 2000 1103 1107
30. P.B. Tabereaux, D.J. Dosdall, and R.E. Ideker Mechanisms of VF maintenance: wandering wavelets, mother rotors, or foci Heart Rhythm 6 2009 405 415
31. T.J. Wu, S.F. Lin, Y.C. Hsieh, Y.T. Chiu, and C.T. Ting Repetitive endocardial focal discharges during ventricular fibrillation with prolonged global ischemia in isolated rabbit hearts Circ J 73 2009 1803 1811
32. R.E. Ideker, J.M. Rogers, V. Fast, L. Li, G.N. Kay, and S.M. Pogwizd Can mapping differentiate microreentry from a focus in the ventricle? Heart Rhythm 6 2009 1666 1669
33. J.L. Zweier, J.T. Flaherty, and M.L. Weisfeldt Direct measurement of free radical generation following reperfusion of ischemic myocardium Proc Natl Acad Sci U S A 84 1987 1404 1407
34. M.C. Corretti, Y. Koretsune, H. Kusuoka, V.P. Chacko, J.L. Zweier, and E. Marban Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts J Clin Invest 88 1991 1014 1025
35. R. Bolli, B.S. Patel, M.O. Jeroudi, E.K. Lei, and P.B. McCay Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone J Clin Invest 82 1988 476 485
36. S. Sicouri, A. Glass, L. Bellardinelli, and C. Antzelevitch Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations Heart Rhythm 5 2008 1019 1026
37. A. Zaza, L. Belardinelli, and J.C. Shryock Pathophysiology and pharmacology of the cardiac "late sodium current." Pharmacol Ther 119 2008 326 339
38. A. Burashnikov, J.M. Di Diego, A.C. Zygmunt, L. Belardinelli, and C. Antzelevitch Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine Circulation 116 2007 1449 1457
39. B.M. Scirica, D.A. Morrow, and H. Hod Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation 116 2007 1647 1652
40. A. Jahangir, S. Sagar, and A. Terzic Aging and cardioprotection J Appl Physiol 103 2007 2120 2128
41. T. Ide, H. Tsutsui, and S. Kinugawa Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium Circ Res 86 2000 152 157
42. A.K. Dhalla, W.Q. Wang, and J. Dow Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion Am J Physiol Heart Circ Physiol 297 2009 H1923 H1929